| Real-world experience with caplacizumab in the management of acute TTP T Dutt, RJ Shaw, M Stubbs, J Yong, B Bailiff, T Cranfield, MP Crowley, ... Blood, The Journal of the American Society of Hematology 137 (13), 1731-1740, 2021 | 126 | 2021 |
| Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI PLR Nicolson, CE Hughes, S Watson, SH Nock, AT Hardy, CN Watson, ... haematologica 103 (12), 2097, 2018 | 71 | 2018 |
| Low-dose Btk inhibitors selectively block platelet activation by CLEC-2 PLR Nicolson, SH Nock, J Hinds, L Garcia-Quintanilla, CW Smith, ... Haematologica 106 (1), 208, 2021 | 63 | 2021 |
| Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases MH Harbi, CW Smith, PLR Nicolson, SP Watson, MR Thomas Platelets 32 (1), 29-41, 2021 | 43 | 2021 |
| A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors PLR Nicolson, JD Welsh, A Chauhan, MR Thomas, ML Kahn, SP Watson Platelets 31 (5), 685-690, 2020 | 42 | 2020 |
| Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib N Cooper, I Altomare, MR Thomas, PLR Nicolson, SP Watson, ... Therapeutic Advances in Hematology 12, 20406207211010875, 2021 | 41 | 2021 |
| Antiplatelet drugs block platelet activation by VITT patient serum CW Smith, SJ Montague, C Kardeby, Y Di, GC Lowe, WA Lester, ... Blood, The Journal of the American Society of Hematology 138 (25), 2733-2740, 2021 | 36* | 2021 |
| Optimizing platelet GPVI inhibition versus haemostatic impairment by the Btk inhibitors ibrutinib, acalabrutinib, ONO/GS-4059, BGB-3111 and evobrutinib V Denzinger, K Busygina, J Jamasbi, I Pekrul, M Spannagl, C Weber, ... Thrombosis and Haemostasis 119 (03), 397-406, 2019 | 35 | 2019 |
| The survival time of chocolates on hospital wards: covert observational study PR Gajendragadkar, DJ Moualed, PLR Nicolson, FD Adjei, ... BMJ 347, 2013 | 33 | 2013 |
| S100A8/A9 drives the formation of procoagulant platelets through GPIbα M Colicchia, WC Schrottmaier, G Perrella, JS Reyat, J Begum, A Slater, ... Blood, The Journal of the American Society of Hematology 140 (24), 2626-2643, 2022 | 30 | 2022 |
| Post-translational polymodification of b1-tubulin regulates motor protein localization in platelet production and function AO Khan, A Slater, A Maclachlan, PLR Nicolson, JA Pike, JS Reyat, ... Haematologica 107 (1), 243, 2022 | 26 | 2022 |
| Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma C Ludwig, DS Williams, DB Bartlett, SJ Essex, G McNee, JW Allwood, ... Blood cancer journal 5 (10), e359-e359, 2015 | 26 | 2015 |
| High-throughput platelet spreading analysis: a tool for the diagnosis of platelet-based bleeding disorders AO Khan, A Maclachlan, GC Lowe, PLR Nicolson, R Al Ghaithi, ... Haematologica 105 (3), e124, 2020 | 23 | 2020 |
| Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib N Cooper, W Ghanima, QA Hill, PLR Nicolson, V Markovtsov, C Kessler Platelets 34 (1), 2131751, 2023 | 20 | 2023 |
| Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months SJ Montague, CW Smith, CS Lodwick, C Stoneley, M Roberts, GC Lowe, ... Research and practice in thrombosis and haemostasis 6 (3), e12707, 2022 | 16* | 2022 |
| The clinical course of COVID‐19 in pregnant versus non‐pregnant women requiring hospitalisation: results from the multicentre UK CA‐COVID‐19 study C Crossette‐Thambiah, P Nicolson, I Rajakaruna, A Langridge, Z Sayar, ... British journal of haematology 195 (1), 85-89, 2021 | 15 | 2021 |
| Antiprothrombin antibodies induce platelet activation: a possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome? W Chayoua, PLR Nicolson, JCM Meijers, C Kardeby, L Garcia‐Quintanilla, ... Journal of Thrombosis and Haemostasis 19 (7), 1776-1782, 2021 | 15 | 2021 |
| Impact of alemtuzumab scheduling on graft-versus-host disease after unrelated donor fludarabine and melphalan allografts K Green, K Pearce, RS Sellar, L Jardine, PLR Nicolson, S Nagra, V Bigley, ... Biology of Blood and Marrow Transplantation 23 (5), 805-812, 2017 | 15 | 2017 |
| Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry S Kemble, A Dalby, GC Lowe, PLR Nicolson, SP Watson, Y Senis, ... Blood advances 6 (9), 2932-2946, 2022 | 14 | 2022 |
| GPVI and CLEC-2 EJ Haining, PLR Nicolson, MB Onselaer, NS Poulter, J Rayes, ... Platelets, 213-226, 2019 | 11 | 2019 |
Steve P. WatsonUniversity of BirminghamVerified email at bham.ac.uk
